rdf:type |
|
lifeskim:mentions |
umls-concept:C0021400,
umls-concept:C0027803,
umls-concept:C0036043,
umls-concept:C0205178,
umls-concept:C0282440,
umls-concept:C0442027,
umls-concept:C0874161,
umls-concept:C1096777,
umls-concept:C1257890,
umls-concept:C1443650,
umls-concept:C1522326,
umls-concept:C2603343
|
pubmed:issue |
8
|
pubmed:dateCreated |
2000-3-7
|
pubmed:abstractText |
Previous studies have shown oseltamivir, a neuraminidase inhibitor, to be effective in preventing influenza and treating experimental influenza.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0098-7484
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
23
|
pubmed:volume |
283
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1016-24
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10697061-Acetamides,
pubmed-meshheading:10697061-Acute Disease,
pubmed-meshheading:10697061-Adult,
pubmed-meshheading:10697061-Antiviral Agents,
pubmed-meshheading:10697061-Double-Blind Method,
pubmed-meshheading:10697061-Drug Administration Schedule,
pubmed-meshheading:10697061-Enzyme Inhibitors,
pubmed-meshheading:10697061-Female,
pubmed-meshheading:10697061-Humans,
pubmed-meshheading:10697061-Influenza, Human,
pubmed-meshheading:10697061-Male,
pubmed-meshheading:10697061-Middle Aged,
pubmed-meshheading:10697061-Neuraminidase,
pubmed-meshheading:10697061-Oseltamivir,
pubmed-meshheading:10697061-Severity of Illness Index,
pubmed-meshheading:10697061-Statistics, Nonparametric
|
pubmed:year |
2000
|
pubmed:articleTitle |
Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group.
|
pubmed:affiliation |
Infectious Diseases Unit, University of Rochester, NY 14642, USA. john_treanor@urmc.rochester.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|